Patented Medicines Prices Review Board: Webinar Invitation
You are invited to join us for an information session highlighting the findings of our latest publication:
Generics360: Generic drugs in Canada, 2016
On January 16, 2018, the Patented Medicine Prices Review Board through the National Prescription Drug Utilization Information System (NPDUIS) research initiative will release its most recent study on the generic drug market in Canada. This report examines trends in Canadian and international generic sales, utilization and pricing, including market segment analyses and an analysis of the potential cost implications for public drug plans.
Two information sessions will be offered on Wednesday January 17th through GoToWebcast. Please choose the one that is most convenient for you. The presentation of results will be in English, and questions will be answered in either English and French.
For any questions or concerns, contact Manon Drouin at email@example.com
Please feel free to extend this invitation to those in your group that may be interested.
Info Session #1 – Wednesday, January 17, 11AM to 12PM
Please register for Information Session – Generics360: Generic drugs in Canada, 2016, on Jan 17, 2018 11:00 AM EDT at:
Info Session #2 – Wednesday, January 17, 2PM to 3PM
Please register for Information Session – Generics360: Generic drugs in Canada, 2016, on Jan 17, 2018 2:00 PM EDT at:
After registering, you will receive a confirmation email containing information about joining the webinar.